Abstract
Over the last two decades, microRNAs (miRNAs) have emerged as a novel class of small non-coding RNAs that fine-tune the expression of various target genes at a post-transcriptional level. Recent studies have highlighted the functional roles of miR-802 in different pathological and physiological conditions. By means of different molecular techniques, including high throughput and gene silencing ones, miR-802 aberrant expression and some of its targets and mechanisms of action have been determined in obesity, glucose metabolism, different types of cancers, Down syndrome, nephropathy, and immune system-mediated conditions. Herein, we review the current knowledge about promising applications of miR-802 in human diseases as biomarkers and therapeutic targets.
Publisher
AMG Transcend Association
Subject
Molecular Biology,Molecular Medicine,Biochemistry,Biotechnology
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献